Secular trends of blood isolates in patients from a rural area population hospitalized in a tertiary center in a small city in Greece by Falagas, Matthew E et al.
BioMed  Central
Page 1 of 6
(page number not for citation purposes)
BMC Microbiology
Open Access Research article
Secular trends of blood isolates in patients from a rural area 
population hospitalized in a tertiary center in a small city in Greece
Matthew E Falagas*1,2, Alexandra Bakossi3, Vasilis D Pappas1, 
Pierros V Holevas3, Antonis Bouras3 and Eleni Stamata3
Address: 1Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece, 2Department of Medicine, Tufts University School of Medicine, Boston, 
Massachusetts, USA and 3Department of Microbiology, General Hospital of Tripolis, Tripolis, Peloponnesus, Greece
Email: Matthew E Falagas* - m.falagas@aibs.gr; Alexandra Bakossi - secretariat@aibs.gr; Vasilis D Pappas - v.pappas@aibs.gr; 
Pierros V Holevas - secretariat@aibs.gr; A n t o n i sB o u r a s-s e c r e t a r i a t @ a i b s . g r ;  Eleni Stamata - secretariat@aibs.gr
* Corresponding author    
Abstract
Background: Most of the studies evaluating the secular trends of blood isolates come from
tertiary hospitals in urban areas. We sought to study the trends of the antimicrobial resistance of
blood isolates in patients from a rural population hospitalized in a tertiary hospital in a small city in
Greece.
Methods: We retrospectively collected and analysed data for the first positive blood culture
obtained for each admission for each patient hospitalized in General Hospital of Tripolis, Tripolis,
Peloponnesus, Greece during a 5 year period (16/05/2000 – 15/05/2005).
Results: Sixty-seven thousand and seventy patients were hospitalized during the study period from
whom 3,206 blood cultures were obtained. A higher increase of the number of obtained blood
cultures than the number of admissions was noted during the study period (p < 0.001). Three
hundred and seventy-three (11.6%) blood cultures were positive. Coagulase-negative staphylococci
(35.9%), Escherichia coli (29%), and Staphylococcus aureus (18.2%) were the most commonly isolated
pathogens. Among the Staphylococcus aureus isolates, the proportion of methicillin-resistant
Staphylococcus aureus (MRSA) was 17.2% (5/29). The proportion of Escherichia coli resistant to
trimethoprim and sulfamethoxazole, ampicillin and cefuroxime was 29.6% (32/108), 25.0% (27/108),
and 8.3% (9/108) respectively. Imipenem-resistance was noted in 3.4% (1/29) of Pseudomonas
aeruginosa isolates. There were only 6 (1.6%) Acinetobacter baummanii blood isolates during the
study period.
Conclusion: The antimicrobial resistance of isolates from patients receiving care at the studied
tertiary hospital in a small city in Greece is considerably less compared to that noted in tertiary
hospitals in larger cities of the country.
Background
There is an increasing incidence of multi drug-resistant
(MDR) bacterial infections in several parts of the world
[1]. However, the majority of the studies on the secular
trends of antimicrobial resistance have been performed in
tertiary medical centers in large cities. There is relatively
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scarcity of information regarding the trends of antimicro-
bial resistance in patients from rural populations hospital-
ized in healthcare centers in small cities. Thus, we sought
to collect and analyze data relevant to this significant pub-
lic health problem from the General Hospital of Tripolis,
a tertiary center serving a rural area of Peloponnesus,
Greece.
Methods
Patient population
The patient population consisted of patients admitted to
the General Hospital of Tripolis, Tripolis, Greece, during
the period of 16/05/2000 – 15/05/2005. The General
Hospital of Tripolis is a 204-bed, tertiary health center
that offers services of most medical specialties, including
medicine, surgery, pediatrics, and obstetrics and gynecol-
ogy. The hospital serves the population of the city of Trip-
olis (40,000 people) and the population of the
surrounding rural area of about 250,000 people (local,
mainly rural population of Central and South Peloponne-
sus, Greece). Our study did not involve any experimenta-
tion on patients. It is a retrospective analysis of
microbiological data. The study was approved by the
Department of Microbiology of General Hospital of Trip-
olis, Greece and by the Ethics Committee of the Alfa Insti-
tute of Biomedical Sciences, Athens, Greece.
Microbiological studies
In our study, isolates of the first positive blood cultures
obtained for each admission for each patient were ana-
lyzed. The isolation of the microorganisms from blood
culture specimens was performed using the Bact/Alert 3D
60 Select (Biomerieux) automated system, according to
the manufacturer's instructions. We focused on Gram-
negative and Gram-positive bacterial isolates. Identifica-
tion of the microorganisms to the species level was per-
formed with the API system (Biomerieux Vitek,
Hazelwood, MO). Gram-negative microorganisms were
identified by the API 20 E strip system, a self-contained
system of 20 microtubes of dehydrated substrates
designed for overnight incubation. Identification is per-
formed by adding necessary reagents and then visually
interpreting the results. The tests included in the system,
are: o-nitrophenyl galactopyranoside (ONPG), arginine
dehydrolase (ADC), lysine and ornithine decarboxylase
(LDC and ODC respectively), citrate (CIT), H2S, urea
(URE), tryptophan deaminase (TDA), indole (IND),
Veges-Proscone (VP), gelatin (GEL), glucose (GLU), man-
nitol (MAN), inositol (INO), sorbitol (SOR), rhamnose
(RHA), sucrose (SAC), melibiose (MEL), amygdalin
(AMY), and arabinose (ARA). Numerical coding of results
allows computerized interpretation of patterns, lists of
which are available in a codebook. Streptococci were
identified with the API 20 strep system. Staphylococcus
aureus  was differentiated from other catalase-positive,
Gram-positive cocci by mannitol salt agar. Pseudomonas
species were identified with the use of the oxidase test. The
fungi isolates were Candida but they were not further
identified to the species level.
Bacterial isolation was followed by antimicrobial suscep-
tibility testing that was performed using the disc diffusion
in Mueller-Hinton agar and measurement of the diameter
of the inhibition zones technique. The antibiotic discs
that we used were provided by MAST Diagnostics, Mast
Group Ltd, Bootle, Merseyside, United Kingdom. The
diameters of microbial inhibition were interpreted based
on the relevant guidelines regarding the cutoff diameters
of the Clinical and Laboratory Standards Institute (CLSI,
formerly called NCCLS) for each antibiotic tested,
depending on the microbial species (NCCLS volume 21-
1, M2-A7 document). In our study we included data
regarding the in vitro susceptibility of blood isolates to
antimicrobial agents only if they were available for the
whole 5-year study period, except for results of in vitro
susceptibility testing of S. aureus and coagulase negative
staphylococci to oxacillin and penicillin.
Table 1: Number of admissions and total and positive blood cultures during each study period in General Hospital of Tripolis, Greece 
(16/05/2000–15/05/2005).
Hospital admission period
2001 2002 2003 2004 2005 2001–2005 (total) p-value
Hospitalized patients 12,625 12,655 13,559 13,835 14,396 67,070 < 0.001
Number of blood cultures 
obtained
406 483 650 763 904 3,206 < 0.001
Ratio of admissions to blood 
cultures obtained
31:1 26:1 21:1 18:1 16:1 21:1
Positive blood cultures 
(proportion from blood cultures 
obtained)
46 (11.3) 48 (9.9) 71 (10.9) 88 (11.5) 120 (13.3) 373 (11.6) 0.39BMC Microbiology 2006, 6:41 http://www.biomedcentral.com/1471-2180/6/41
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Statistical analysis
Differences in proportions were compared by x2 test or
Fischer exact test if the numbers of the studied was small
(less than 6 in any of the compared cells of observations).
The statistical significance was set at the level p < 0.05. All
statistical analyses were performed using SPSS 11.0 (SPSS
Inc., Chicago, Illinois, USA).
Results
During the study period, 67,070 patients were hospital-
ized at the General Hospital of Tripolis and 3,206 blood
cultures were performed. The annual number of admis-
sions in the hospital, the number of blood cultures per-
formed, and the proportion of positive cultures per year
are presented in Table 1. A gradual increase of the number
of admissions and the number of blood cultures was
noted during the study period (p < 0.001). Compared to
data of the first year of the study a 14.1% and 122.7%
increase of the number of admissions and the number of
performed blood cultures, respectively, was noted during
the fifth year of the study. On the other hand the propor-
tion of positive blood cultures did not significantly
increase (p = 0.39) resulting in bloodstream infection
rates remaining stable over the 5-year period (between
9.9%–13.3%).
Data regarding the isolated microorganisms from the first
positive blood culture for each patient for each admission
during the study period are presented in Table 2. Gram-
positive bacteria were the most common isolates. Coagu-
lase-negative staphylococci comprised 35.9% of the total
isolates. Following, in descending order, Escherichia coli
comprised 29.0%, S. aureus 18.2%, Pseudomonas aerugi-
nosa 7.8%, Acinetobacter baumannii 1.6%,Proteus mirabilis
1.6%, and Klebsiella pneumoniae 1.1%. The statistical anal-
ysis did not yield significant changes in the proportion of
isolates of different species during the 5-year period. The
analysis of the relative frequency of blood isolates per year
showed that E. coli comprised the commonest isolate dur-
ing the first and second year of the study while it became
the second commonest after coagulase-negative staphylo-
cocci during the last 3 years of the study (p = 0.01). The p-
values for the comparison of the frequency of isolates of
different species during the study period were 0.28, 0.06,
and 0.45 for coagulase-negative staphylococci, E. coli and
S. aureus, respectively. A. baumannii blood isolates were
reported for the first time during the third year of the
study.
The results of the analysis of the available data of the in
vitro antimicrobial testing of blood isolates during the
study period are presented in Table 3. The proportion of
methicillin-resistant S. aureus (MRSA) was 17.2% (5/29);
no in vitro antimicrobial susceptibility testing of staphy-
lococcal isolates to oxacillin was performed during the
last 2 years of the study due to the unavailability of the rel-
evant discs with the antibiotic. The proportion of E. coli
resistant to trimethoprim and sulfamethoxazole, ampicil-
lin, and cefuroxime was 29.6% (32/108), 25.0% (27/
108), and 8.3% (9/108) respectively. The proportion of E.
Table 2: Relative frequency of blood isolates in General Hospital of Tripolis, Greece (2001–2005).
Number of isolates (proportion) within the specified periods*
Microorganisms 2001 2002 2003 2004 2005 Total p-value
Gram-positive
Coagulase-negative staphylococci 15 (32.6) 15 (31.3) 26 (36.6) 26 (29.5) 52 (43.3) 134 (35.9) 0.28
Stapylococcus aureus 6 (13) 9 (18.8) 14 (19.7) 21 (23.9) 18 (15) 68 (18.2) 0.45
Streptococcus viridans 1 (1.4) 1 (0.3)
Gram-negative
Escerichia coli 20 (43.5) 17 (35.4) 22 (31) 22 (25) 27 (22.5) 108 (29) 0.06
Pseudomonas aeruginosa 2 (4.3) 3 (6.3) 4 (5.6) 11 (12.5) 9 (7.5) 29 (7.8)
Acinetobacter baumannii 3 (4.2) 2 (2.3) 1 (0.8) 6 (1.6)
Proteus mirabilis 1 (2.2) 3 (6.3) 0(0) 0(0) 2 (1.6) 6 (1.6)
Klebsiella pneumoniae 1 (2.2) 1 (2.1) 0(0) 0(0) 2 (1.6) 4 (1.1)
Enterobacter 1 (1.4) 1 (0.3)
Candida spp 1 (2.2) 4 (4.6) 7 (5.8) 12 (3.2)
Miscellaneous Gram-negative
Serratia marscescens 1 (0.8) 1 (0.3)
Morganella morgannii 1 (1.1) 1 (0.3)
Citrobacter 1 (1.1) 1 (0.3)
Achromobacter 1 (0.8) 1 (0.3)
TOTAL 46 (100) 48 (100) 71 (100) 88 (100) 120 (100) 373 (100)
* for the isolate of the first positive blood cultureBMC Microbiology 2006, 6:41 http://www.biomedcentral.com/1471-2180/6/41
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coli isolates resistant to trimethoprim and sulfamethoxa-
zole did not alter during the study period (p = 0.71). Imi-
penem-resistance was noted in 3.4% (1/29) of
Pseudomonas aeruginosa isolates. There were only 6 (1.6%)
Acinetobacter baummanii blood isolates during the study
period. An imipenem-resistant A. baumanni strain was iso-
lated during the fifth year of the study.
Discussion
Most of the studies that report increased trends in resist-
ance to antimicrobial agents have been performed in ter-
tiary urban hospitals. Comparisons of reported data of
nosocomial infections among hospitals of different bed
sizes show that the risk of developing nosocomial infec-
tion and hospital-acquired bacteremia is directly associ-
Table 3: Trends of antimicrobial resistance of Gram-positive and Gram-negative bacteria in General Hospital of Tripolis, Greece 
(2001–2005).
Number of resistant isolates/total isolates (proportion) within the year
Microorganisms 2001 2002 2003 2004 2005 Total
Gram-positive
Staphylococcus 
epidermidis
Oxacillin* 0/15 (0) 6/15 (40) 7/26 (26.9) 13/56 (23.2)
Gentamicin 2/15 (13.3) 1/15 (6.7) 1/26 (3.8) 0/26 (0) 9/52 (17.3) 13/134 (9.7)
Vancomycin 0/15 (0) 0/15 (0) 0/26(0) 0/26 (0) 0/52 (0) 0/134 (0)
Penicillin 13/26 (50) 40/52 (76.9) 53/78 (67.9)
Staphylococcus 
aureus
Oxacillin* 0/6 (0) 5/9 (55.6) 0/14 (0) 5/29 (17.2)
Gentamicin 1/6 (16.7) 1/9 (11.1) 0/14 (0) 3/21 (14.3) 1/18 (5.6) 6/68 (8.8)
Vancomycin 0/6 (0) 0/9 (0) 0/14 (0) 0/21 (0) 0/18 (0) 0/68 (0)
Penicillin 14/21 (66.7) 13/18 (72.2) 27/39 (69)
Streptococcus 
viridans
Penicillin 0/1 (0) 0/1 (0)
Vancomycin 0/1 (0) 0/1 (0)
Gram-negative
Escherichia coli
Trimethoprim-
sulfamethoxazole
8/20 (40) 6/17 (35.2) 6/22 (27.2) 6/22 (27.2) 6/27 (22.2) 32/108 (29.6)
Amikacin 8/20 (40) 4/17 (23.5) 1/22 (4.5) 0/22 (0) 6/27 (22.2) 19/108 (17.6)
Gentamicin 2/20 (10) 4/17 (23.5) 0/22 (0) 0/22 (0) 2/27 (7.4) 8/108 (7.4)
Ampicillin 3/20 (15) 0/17 (0) 6/22 (27.2) 8/22 (36.3) 10/27 (37.0) 27/108 (25.0)
Cefuroxime 0/20 (0) 0/17 (0) 2/22 (9.1) 1/22 (4.5) 6/27 (22.2) 9/108 (8.3)
Pseudomonas 
aeruginosa
Amikacin 0/2 (0) 0/3 (0) 0/4 (0) 0/11 (0) 3/9 (33.3) 3/29 (10.3)
Ceftazidime 0/2 (0) 0/3 (0) 0/4 (0) 2/11 (18.2) 2/9 (22.2) 4/29 (13.8)
Ciprofloxacin 1/2 (50) 0/3 (0) 0/4 (0) 4/11 (36.4) 3/9 (33.3) 8/29 (27.6)
Imipenem 0/2 (0) 0/3 (0) 0/4 (0) 0/11 (0) 1/9 (11.1) 1/29 (3.4)
Acinetobacter 
baumanii
Amikacin 0/3 (0) 1/2 (50) 0/1 (0) 1/6 (16.7)
Gentamicin 0/3 (0) 0/2 (0) 0/1 (0) 0/6 (0)
Ceftazidime 3/3 (100) 1/2 (50) 0/1 (0) 4/6 (66.7)
Ciprofloxacin 3/3 (100) 2/2 (100) 0/1 (0) 5/6 (83.3)
Imipenem 0/3 (0) 0/2 (0) 1/1 (100) 0/6 (0)
Klebsiella 
pneumoniae
Ceftazidime 0/1 (0) 0/2 (0) 0/3 (0)
Ciprofloxacin 0/1 (0) 1/2 (50) 1/3 (33.3)
Meropenem 0/1 (0) 0/2 (0) 0/3 (0)
Cefepime 0/1 (0) 0/2 (0) 0/3 (0)
Cefoxitin 1/1 (100) 0/2 (0) 1/3 (33.3)
Tobramycin 0/1 (0) 0/2 (0) 0/3 (0)
* Oxacillin discs were not available for antimicrobial testing during the period 16/05/2003 – 15/05/2005BMC Microbiology 2006, 6:41 http://www.biomedcentral.com/1471-2180/6/41
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ated with the size of each hospital [2-4]. In addition,
another observation is that MDR strains are more com-
monly isolated in large than in small hospitals [3,5,6].
Our study suggests that another factor besides the hospital
size that is associated with the proportion of MDR isolates
may be the location of a hospital, i.e. whether the health
care facility is in a large or a small city. This may be par-
tially explained by differences in the morbidity of the
average patient and antibiotic prescription policies of hos-
pitals of same size in large and small cities. However,
another epidemiologic reason leading to differences of
antimicrobial resistance of isolates of patients who receive
care in hospitals in large and small cities may be the fact
that patients are more likely to be transferred from one
hospital to another in large cities. This is especially true in
countries such as Greece where transfer of patients
between hospitals is not uncommon, for example transfer
from a private to a public hospital or the reverse.
An interesting finding of our analysis concerns the dispro-
portionate increase of the number of obtained blood cul-
tures compared to the increase of the number of
admissions during the study period. Annual increase in
the number of performed blood cultures is a finding that
has been reported by investigators in other studies as well
[7,8]. We consider that this is partly attributed to thera-
peutic policies adherent to current guidelines that suggest
obtaining blood cultures in various patient populations
[9].
The major isolates cultured in our study, were coagulase
negative staphylococci, E. coli, and S. aureus. Totally,
Gram-positive bacterial isolates were more common, than
Gram-negative. These findings are in keeping with results
reported from other hospitals [10]. It is noteworthy that
while during the first study period gram-negative blood-
stream infection was more pronounced, gram-positive
bacteremia prevailed during the last period, defining in
this way a shift in the causative pathogens [11].
The commonest type of blood isolate during the study
period was coagulase negative staphylococci. This may be
misleading, as a great proportion of coagulase negative
staphylococci isolates obtained from blood cultures, are
contaminants and not true agents of blood stream infec-
tion [12,13]. The inclusion of each patient's first positive
blood culture only, comprises a limitation to the interpre-
tation of these data. However, coagulase negative staphy-
lococci, once isolated, should be always taken into
account as an agent potentially responsible for bacteremia
in severely ill patients, when we decide about the thera-
peutic regimen [14,15].
The number of blood cultures yielding Candida isolates,
also increased during the study period. Such an increase is
reported in other studies as well and is attributed to many
factors, including the vigorous use of broad-spectrum
antibiotics, the increased length of survival of immuno-
compromised patients, the presence of indwelling cathe-
ters [16,17].
Regarding the trends in resistance patterns of isolated
pathogens to different antimicrobial regimens, an increas-
ing trend of the resistance of isolated P. aeruginosa strains
to amikacin, ceftazidime and imipenem was noted during
the last period of our study. An optimistic observation was
the fact that MDR A. baumanii was uncommonly isolated
in the hospital of our study [18-20].
Conclusion
In summary, we found that the antimicrobial resistance of
isolates from patients receiving care at the studied tertiary
hospital in a small city in Greece is considerably less com-
pared to that noted in a study of ours using similar meth-
odology in a tertiary hospital in a larger city (Athens) of
our country [21].
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